This award recognises the groundbreaking work behind the Brevera® system, which has revolutionised breast biopsy procedures across all HSE-funded breast centres in Ireland. By combining real-time imaging with tissue acquisition, the system enhances accuracy, shortens procedure times, and significantly improves patient comfort.

Winning this award highlights HSL’s commitment to driving innovation and delivering solutions that make a real difference in patient care and healthcare efficiency. We are incredibly proud of our collaboration with Hologic, Inc., and the positive impact this system has had on breast cancer diagnostics in Ireland.

A heartfelt thank you to Health Tech Ireland for this incredible recognition and to all our partners and team members who contributed to this success. Together, we’re transforming the future of diagnostic care.

The post HSL Wins Health Tech Ireland Award for Transformative Innovation in Diagnostics appeared first on Hospital Services Limited UK.

The Hologic Brevera® system represents a major leap forward in breast biopsy procedures, significantly enhancing accuracy, reducing procedure times, and improving patient comfort across all HSE-funded breast centres in Ireland. This system integrates real-time imaging with tissue acquisition, allowing clinicians to assess tissue quality in seconds, which minimizes patient wait times and enhances overall efficiency.

This nomination underscores our commitment to healthcare innovation and patient-centered solutions. HSL is proud to be recognised for our contributions to the future of diagnostic care in Ireland, and we look forward to continuing our work to bring transformative health technology to the communities we serve.

The post HSL Shortlisted for Health Tech Ireland Award for Transformative Impact in Diagnostics appeared first on Hospital Services Limited UK.